PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28724200-0	2018	Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury.	Memantine	10-19	enolase 2	Homo sapiens	39-62	
28724200-3	2018	We examined the effect of memantine on serum levels of neuron-specific enolase (NSE), a marker of neuronal damage, and the Glasgow Coma Scale (GCS) in patients with moderate TBI.	Memantine	26-35	enolase 2	Homo sapiens	55-78	
28724200-3	2018	We examined the effect of memantine on serum levels of neuron-specific enolase (NSE), a marker of neuronal damage, and the Glasgow Coma Scale (GCS) in patients with moderate TBI.	Memantine	26-35	enolase 2	Homo sapiens	80-83	
28724200-8	2018	The mean serum NSE levels for the memantine and the control groups on day 3 were 7.95 +- 2.86 and 12.33 +- 7.09 ng/mL, respectively (P = .05), and on day 7 were 5.03 +- 3.25 and 10.04 +- 5.72 ng/mL, respectively (P = .003).	Memantine	34-43	enolase 2	Homo sapiens	15-18	
28724200-11	2018	Patients with moderate TBI who received memantine had significantly reduced serum NSE levels by day 7 and marked improvement in their GCS scores on day 3 of the study.	Memantine	40-49	enolase 2	Homo sapiens	82-85